Search - tctmd.com

Displaying 61 - 80 of 83

Sort: Relevancy | Date

News Daily News

No Rebound Effect after Clopidogrel Cessation in Stable Patients

December 05, 2013

Presentation

The Dark Side of SVG

Presenter: Ezri Rozenbaum

December 02, 2013

News Conference News TCT 2013

At a Transradial PCI Center, Transfemoral Patients Undergo More Complex Procedures, Have Poorer Outcomes

October 28, 2013

Presentation TCT 2013

Complex Coronary Lesions (Left Main, Bifurcations, CTO, SVGs)

Presenter: Tayo Addo

October 27, 2013

Presentation SOLACI 2013

SVG Interventions: Progress or Dead-End?

Presenter: Conrad Simpfendorfer

July 26, 2013

News Opinion Conversations in Cardiology

Conversations in Cardiology: Bridging Antithrombotic Therapy Between PCI & CABG

June 03, 2013

News Opinion Conversations in Cardiology

Conversations in Cardiology: Q&A

February 13, 2013

Presentation

Discontinuation of Long-term Clopidogrel Therapy Is Associated with Death and MI After SVG PCI

Presenter: A. Sachdeva

November 13, 2012

News Daily News

Risk Peaks Early After Clopidogrel Cessation in SVG PCI Patients

November 13, 2012

Presentation TCT 2012

Treatment of Multiple Huge SVG Aneurysms: Stent or Surgery?

Presenter: Kristina Maric

October 24, 2012

Presentation TCT 2012

Prospective Evaluation Of the Xience V Everolimus-Eluting Stent In Saphenous Vein Graft Atherosclerosis: the Xience V-SVG Angiographic Study.

Presenter: Emmanouil S. Brilakis, Aristotelis C. Papayannis, Abdul-rahman R. Abdel-karim, Tesfaldet T. Michael, Arif Mahmood, Lorenza B. Makke, Michele Roesle, Donald Haagen, Bavana V. Rangan, Subhash Banerjee

January 03, 2012

News Conference News

ADAPT-DES: Risk of Early Stent Thrombosis in DES Predicted by Platelet Inhibition

November 09, 2011

News Industry News

Risk of late stent thrombosis continues for up to seven years in patients with first generation drug-eluting stents; risk factors identified

November 08, 2011

News Daily News

ISAR-CABG Published: DES Preferred for Saphenous Vein Graft Lesions

Jason Kahn

September 12, 2011

News Industry News

Medtronic Resolute® Drug-Eluting Stent Offers Strong Performance in Diabetic Patients with Heart Disease

May 18, 2011

News Daily News

Bleeding Increases Mortality as Late as 3 Years After DES

Leah Lawrence

April 18, 2011

News Conference News

RAPS: Radial Arteries Superior to Saphenous Vein Grafts at 5 Years After CABG

Caitlin E. Cox

April 13, 2011

News Conference News

ISAR-CABG: DES Superior to BMS in Saphenous Vein Graft Lesions

Jason Kahn

April 04, 2011

Video

» Live Case

Native LCx CTO PCI using rCART via SVG

February 3, 2024

Video

» Live Case

Calcified RCA CTO PCI using facilitated ADR using SVG as retrograde conduit

February 2, 2024

Advertisement

No Rebound Effect after Clopidogrel Cessation in Stable Patients

The Dark Side of SVG

At a Transradial PCI Center, Transfemoral Patients Undergo More Complex Procedures, Have Poorer Outcomes

Complex Coronary Lesions (Left Main, Bifurcations, CTO, SVGs)

SVG Interventions: Progress or Dead-End?

Conversations in Cardiology: Bridging Antithrombotic Therapy Between PCI & CABG

Conversations in Cardiology: Q&A

Discontinuation of Long-term Clopidogrel Therapy Is Associated with Death and MI After SVG PCI

Risk Peaks Early After Clopidogrel Cessation in SVG PCI Patients

Treatment of Multiple Huge SVG Aneurysms: Stent or Surgery?

Prospective Evaluation Of the Xience V Everolimus-Eluting Stent In Saphenous Vein Graft Atherosclerosis: the Xience V-SVG Angiographic Study.

ADAPT-DES: Risk of Early Stent Thrombosis in DES Predicted by Platelet Inhibition

Risk of late stent thrombosis continues for up to seven years in patients with first generation drug-eluting stents; risk factors identified

ISAR-CABG Published: DES Preferred for Saphenous Vein Graft Lesions

Medtronic Resolute® Drug-Eluting Stent Offers Strong Performance in Diabetic Patients with Heart Disease

Bleeding Increases Mortality as Late as 3 Years After DES

RAPS: Radial Arteries Superior to Saphenous Vein Grafts at 5 Years After CABG

ISAR-CABG: DES Superior to BMS in Saphenous Vein Graft Lesions

Native LCx CTO PCI using rCART via SVG

Calcified RCA CTO PCI using facilitated ADR using SVG as retrograde conduit

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content